Most Tumor Markers are not specific to any type of cancer and the differences between benign and malignant diseases are quantitative (for example, patients with epithelial tumors tend to have significantly higher levels of these Tumor Markers than patients without malignancy). Tumor Markers are parameters released by tumor cells, which enter the bloodstream or other biological fluids and are useful for the diagnosis, prognosis and treatment monitoring. OncoLUNG Dx is based on a score calculation that it is obtained from several Biomarkers of the patient (mainly Tumor Markers but also patient’s clinical information).Ĭlick here to download the brochure in PDF format. It also has potentially uses for screening, prognosis and recurrence monitoring. OncoLUNG Dx is an innovative, non-invasive, accurate, and cost-effective already validated solution to help in Lung Cancer diagnosis as well as confirmatory diagnostic ―as an adjunct to suspicious image procedures findings, in order to reduce the number of unnecessary tissue biopsies that patients have to undergo―.

Download lung cancer diagnosis